Robert Wasserman
Stock Analyst at Benchmark
(3.37)
# 1,015
Out of 5,113 analysts
123
Total ratings
49.53%
Success rate
3.86%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Maintains: Buy | $175 → $220 | $195.49 | +12.54% | 12 | Nov 7, 2025 | |
| PRLB Proto Labs | Maintains: Buy | $45 → $55 | $52.48 | +4.80% | 7 | Nov 3, 2025 | |
| ITGR Integer Holdings | Downgrades: Hold | n/a | $85.79 | - | 12 | Oct 24, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $75 → $90 | $70.22 | +28.17% | 10 | Sep 24, 2025 | |
| INTS Intensity Therapeutics | Maintains: Speculative Buy | $4 → $1.5 | $0.39 | +287.00% | 7 | Aug 20, 2025 | |
| TECH Bio-Techne | Reiterates: Buy | $75 | $68.23 | +9.92% | 7 | Jun 5, 2025 | |
| KMDA Kamada | Reiterates: Buy | $15 | $8.87 | +69.11% | 2 | May 15, 2025 | |
| OABI OmniAb | Reiterates: Buy | $6 | $1.96 | +206.12% | 9 | May 12, 2025 | |
| XOMA XOMA Royalty | Initiates: Buy | $35 | $25.71 | +36.13% | 1 | Apr 17, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $3.99 | - | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $24.98 | +20.10% | 6 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $8 | $0.91 | +779.02% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $4.49 | +11.36% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $12.22 | -1.80% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.43 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $163.63 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $3.51 | +13.96% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $100 | $3.19 | +3,034.80% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $3.46 | +2,067.63% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $235.75 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $623.91 | -7.04% | 1 | Jul 16, 2021 |
Ligand Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $175 → $220
Current: $195.49
Upside: +12.54%
Proto Labs
Nov 3, 2025
Maintains: Buy
Price Target: $45 → $55
Current: $52.48
Upside: +4.80%
Integer Holdings
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $85.79
Upside: -
Halozyme Therapeutics
Sep 24, 2025
Maintains: Buy
Price Target: $75 → $90
Current: $70.22
Upside: +28.17%
Intensity Therapeutics
Aug 20, 2025
Maintains: Speculative Buy
Price Target: $4 → $1.5
Current: $0.39
Upside: +287.00%
Bio-Techne
Jun 5, 2025
Reiterates: Buy
Price Target: $75
Current: $68.23
Upside: +9.92%
Kamada
May 15, 2025
Reiterates: Buy
Price Target: $15
Current: $8.87
Upside: +69.11%
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $1.96
Upside: +206.12%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $25.71
Upside: +36.13%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.99
Upside: -
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $24.98
Upside: +20.10%
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $0.91
Upside: +779.02%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $4.49
Upside: +11.36%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $12.22
Upside: -1.80%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $1.43
Upside: -
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $163.63
Upside: -
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $3.51
Upside: +13.96%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $100
Current: $3.19
Upside: +3,034.80%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $3.46
Upside: +2,067.63%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $235.75
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $623.91
Upside: -7.04%